+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Dermatological Drugs Market Research Reports

Skin Neoplasms - Epidemiology Forecast to 2032 - Product Thumbnail Image

Skin Neoplasms - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Radiodermatitis- Epidemiology Forecast to 2032 - Product Thumbnail Image

Radiodermatitis- Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Systemic Scleroderma - Epidemiology Forecast to 2032 - Product Thumbnail Image

Systemic Scleroderma - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Tinea Pedis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Tinea Pedis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Warts - Epidemiology Forecast to 2032 - Product Thumbnail Image

Warts - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Dermal Erythema - Epidemiology Forecast - 2032 - Product Thumbnail Image

Dermal Erythema - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Dermal Mycosis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Dermal Mycosis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Keloid - Epidemiology Forecast - 2032 - Product Thumbnail Image

Keloid - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Seborrhea - Epidemiology Forecast - 2032 - Product Thumbnail Image

Seborrhea - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Onycholysis - Epidemiology Forecast - 2032 - Product Thumbnail Image

Onycholysis - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Dyschromia - Epidemiology Forecast to 2032 - Product Thumbnail Image

Dyschromia - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Uremic Pruritus - Epidemiology Forecast - 2032 - Product Thumbnail Image

Uremic Pruritus - Epidemiology Forecast - 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Epidermolysis Bullosa - Epidemiology Forecast to 2032 - Product Thumbnail Image

Epidermolysis Bullosa - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
From
Psoriasis Vulgaris - Epidemiology Forecast to 2032 - Product Thumbnail Image

Psoriasis Vulgaris - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Hidradenitis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Hidradenitis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Ichthyosis - Epidemiology Forecast to 2032 - Product Thumbnail Image

Ichthyosis - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Lice Infestations - Epidemiology Forecast to 2032 - Product Thumbnail Image

Lice Infestations - Epidemiology Forecast to 2032

  • Report
  • January 2022
  • 60 Pages
  • Global
From
Loading Indicator

The Dermatological Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat skin conditions. These drugs are used to treat a variety of skin conditions, including acne, eczema, psoriasis, and skin cancer. Dermatological drugs are typically administered topically, although some may be taken orally. The Dermatological Drugs market is highly competitive, with many companies vying for market share. Major players in the market include Johnson & Johnson, GlaxoSmithKline, Pfizer, Merck, and Novartis. These companies are engaged in research and development of new drugs, as well as marketing and distribution of existing products. Additionally, many smaller companies are involved in the production of generic dermatological drugs. Show Less Read more